BioMarin Pharmaceutical announced that its management will present at three upcoming investor conferences in November 2026: the Stifel Healthcare Conference, UBS Global Biopharma Conference, and Jefferies Global Healthcare Conference. These presentations will be available via live audio webcast and archived on the company's website for a limited time. BioMarin is a global biotech company specializing in rare diseases, with a strong portfolio of approved therapies and ongoing clinical development. These events provide an opportunity for investors to hear directly from BioMarin's leadership about company progress and future plans.
BioMarin Pharmaceutical's stock is currently trading at USD 56.85 on Pluang, showing a 1-day gain of 2.14%. The company's market cap stands at $11.12 billion. These figures are as of Nov 04, 2026 21:12 WIB.
